Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 3147 Neoplasms 2478 Carcinoma, Non-Small-Cell Lung 1889 Prostatic Neoplasms 1645 Colorectal Neoplasms 1438 Lung Neoplasms 1312 Multiple Myeloma 940 Neoplasm Metastasis 930 Leukemia, Myeloid, Acute 885 Pancreatic Neoplasms 862 Ovarian Neoplasms 815 Melanoma 794 Carcinoma, Hepatocellular 745 Stomach Neoplasms 650 Brain Neoplasms 643 Recurrence 642 Squamous Cell Carcinoma of Head and Neck 639 Head and Neck Neoplasms 613 Glioblastoma 575 Lymphoma 551 Uterine Cervical Neoplasms 549 Triple Negative Breast Neoplasms 515 Precursor Cell Lymphoblastic Leukemia-Lymphoma 511 Carcinoma, Renal Cell 505 Endometrial Neoplasms 467 Hematologic Neoplasms 466 Urinary Bladder Neoplasms 462 Colonic Neoplasms 448 Sarcoma 439 Lymphoma, Non-Hodgkin 439

Interventions

Elasticity Imaging Techniques 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Pancreas Adenocarcinomas × 1 year × Clear all

NCT06842303 2025-07-17

PADME

Central Hospital, Nancy, France

Phase NA Recruiting

Gastrointestinal

Pancreas Adenocarcinomas

Data powered by HemOnc (CC BY 4.0) Colophon ⚡